[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100487770":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":11,"locations":28,"responsibleParty":57,"collaborators":11,"id":61,"slug":11,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":11,"eligibilityCriteria":66,"healthyVolunteers":62,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":11,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":30,"whyStopped":11,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Chulalongkorn University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Placebo","PLACEBO_COMPARATOR",null,[13],"Drug: Placebo",{"label":15,"type":16,"description":11,"interventionNames":17},"Intervention","EXPERIMENTAL",[18],"Drug: Dexamethasone",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","Dexamethasone","Patients treated with dexamethasone",[15],{"type":21,"name":9,"description":26,"armGroupLabels":27,"otherNames":11},"Patients treated with placebo",[9],[29,46],{"facility":5,"status":30,"city":31,"state":11,"zip":11,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Bangkok","Thailand",{"type":34,"coordinates":35},"Point",[36,37],100.50144,13.75398,{"lat":37,"lon":36},[40],{"name":41,"role":42,"phone":43,"phoneExt":44,"email":45},"Nattachai Srisawat","CONTACT","02-256-4000","3597","drnattachai@yahoo.com",{"facility":47,"status":30,"city":31,"state":11,"zip":11,"country":32,"cosmosGeoPoint":48,"geoPoint":50,"contacts":51},"King Chulalongkorn Memorial Hospital",{"type":34,"coordinates":49},[36,37],{"lat":37,"lon":36},[52],{"name":53,"role":42,"phone":54,"phoneExt":55,"email":56},"Sasipha Tachaboon","6622564000","3679","sasipha_tac@hotmail.com",{"type":58,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Nattachai Srisawat ,M.D.","Principal investigator","100487770",false,"NCT05631405","Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone (DengDex Study)","Efficacy of Dengue Infection With Warning Signs Treated With Dexamethasone","Inclusion Criteria:\n\n* Laboratory confirmed Dengue infected patients (Positive NS1 Ag or anti-DENV IgM by Dengue Duo test)\n* And still in febrile phase (Body temp\\>37.5 C)\n* Shock : Sys\\\u003C90mmHg or Narrow PP (\\\u003C20mmHg) orTachycardia (pulse\\>100\u002Fmin) with Hematocrit decreased ≥20 %\n* Fluid accumulation and respiratory distress\n* Severe bleeding\n* Severe organ involvement\n\nExclusion Criteria:\n\n* Severe dengue\\> 24 hrs\n* Dengue without warning signs\n* Pregnancy\n* Patient who receieved any steroid within 1 week","ALL","7 Years","99 Years",{"count":71,"type":72},200,"ESTIMATED","INTERVENTIONAL",[75],"NA","The goal of this randomized double-blinded placebo-controlled trial is to learn about dexamethasone and the treatment of severe dengue population. The main question it aims to answer are steroid therapy may be effective in dengue.",[78],"Severe Dengue",[78,22,80],"Steroid","2026-06-15",{"date":83,"type":84},"2026-06-16","ACTUAL",{"date":86,"type":84},"2022-10-16",{"date":88,"type":72},"2027-12-31",{"name":5,"class":6},2]